These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 37728227

  • 1. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
    Guindo A, Cisse Z, Keita I, Desmonde S, Sarro YDS, Touré BA, Baraika MA, Tessougué O, Guindo P, Coulibaly M, Traore O, Sylla N, Diassana M, Saye A, Picot V, Lauressergues E, Leroy V.
    Br J Haematol; 2024 Jan; 204(1):337-345. PubMed ID: 37728227
    [Abstract] [Full Text] [Related]

  • 2. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
    Nnodu OE, Sopekan A, Nnebe-Agumadu U, Ohiaeri C, Adeniran A, Shedul G, Isa HA, Owolabi O, Chianumba RI, Tanko Y, Iyobosa JH, Adekile AD, Olopade OI, Piel FB.
    Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
    [Abstract] [Full Text] [Related]

  • 3. Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.
    Adegoke SA, Makalo L, Sallah A, Saine H, Joof S, Conteh A, Bah R, Camara Jammeh AF, Bass M, Jallow M, Nnodu OE.
    Hemoglobin; 2024 May; 48(3):169-174. PubMed ID: 38980121
    [Abstract] [Full Text] [Related]

  • 4. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
    Steele C, Sinski A, Asibey J, Hardy-Dessources MD, Elana G, Brennan C, Odame I, Hoppe C, Geisberg M, Serrao E, Quinn CT.
    Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
    [Abstract] [Full Text] [Related]

  • 5. MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC.
    El Osta M, Benoist JF, Naubourg P, Bonacorsi S, Messine R, Ducoroy P, Allaf B.
    Clin Chem Lab Med; 2024 May 27; 62(6):1149-1157. PubMed ID: 38353144
    [Abstract] [Full Text] [Related]

  • 6. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
    Oluwole EO, Adeyemo TA, Osanyin GE, Odukoya OO, Kanki PJ, Afolabi BB.
    PLoS One; 2020 May 27; 15(12):e0242861. PubMed ID: 33270733
    [Abstract] [Full Text] [Related]

  • 7. Screening for haemoglobin disorders: One size may not fit all.
    Shook LM, Ware RE.
    Br J Haematol; 2024 Jan 27; 204(1):26-28. PubMed ID: 37877454
    [Abstract] [Full Text] [Related]

  • 8. Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India.
    Mukherjee MB, Colah RB, Mehta PR, Shinde N, Jain D, Desai S, Dave K, Italia Y, Raicha B, Serrao E.
    Am J Clin Pathol; 2020 Jan 01; 153(1):82-87. PubMed ID: 31433854
    [Abstract] [Full Text] [Related]

  • 9. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
    Colombatti R, Martella M, Cattaneo L, Viola G, Cappellari A, Bergamo C, Azzena S, Schiavon S, Baraldi E, Dalla Barba B, Trafojer U, Corti P, Uggeri M, Tagliabue PE, Zorloni C, Bracchi M, Biondi A, Basso G, Masera N, Sainati L.
    Pediatr Blood Cancer; 2019 May 01; 66(5):e27657. PubMed ID: 30724025
    [Abstract] [Full Text] [Related]

  • 10. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
    Diallo DA, Guindo A, Touré BA, Sarro YS, Sima M, Tessougué O, Baraika MA, Guindo P, Traoré M, Diallo M, Dorie A.
    Rev Epidemiol Sante Publique; 2018 May 01; 66(3):181-185. PubMed ID: 29625861
    [Abstract] [Full Text] [Related]

  • 11. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.
    Allaf B, Patin F, Elion J, Couque N.
    Pediatr Blood Cancer; 2018 Sep 01; 65(9):e27230. PubMed ID: 29781571
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic accuracy in field conditions of the sickle SCAN® rapid test for sickle cell disease among children and adults in two West African settings: the DREPATEST study.
    Segbena AY, Guindo A, Buono R, Kueviakoe I, Diallo DA, Guernec G, Yerima M, Guindo P, Lauressergues E, Mondeilh A, Picot V, Leroy V.
    BMC Hematol; 2018 Sep 01; 18():26. PubMed ID: 30237894
    [Abstract] [Full Text] [Related]

  • 13. Strategy linking several analytical methods of neonatal screening for sickle cell disease.
    Ducrocq R, Pascaud O, Bévier A, Finet C, Benkerrou M, Elion J.
    J Med Screen; 2001 Sep 01; 8(1):8-14. PubMed ID: 11373853
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease.
    McGann PT, Schaefer BA, Paniagua M, Howard TA, Ware RE.
    Am J Hematol; 2016 Feb 01; 91(2):205-10. PubMed ID: 26537622
    [Abstract] [Full Text] [Related]

  • 15. A Paper-Based Test for Screening Newborns for Sickle Cell Disease.
    Piety NZ, George A, Serrano S, Lanzi MR, Patel PR, Noli MP, Kahan S, Nirenberg D, Camanda JF, Airewele G, Shevkoplyas SS.
    Sci Rep; 2017 Apr 03; 7():45488. PubMed ID: 28367971
    [Abstract] [Full Text] [Related]

  • 16. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P, Ayyappan S, Nouraie M, Saraf S, Gordeuk V, Hostetter T, Gladwin MT, Little J.
    Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):207-15. PubMed ID: 26672090
    [Abstract] [Full Text] [Related]

  • 17. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
    Christopher H, Josephat E, Kaywanga F, Saul S, Mshana I, Kunambi P, Nasser A, Chamba C, Makani J, Nkya S.
    Int J Lab Hematol; 2022 Oct 05; 44(5):959-965. PubMed ID: 35775883
    [Abstract] [Full Text] [Related]

  • 18. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease.
    Moat SJ, Rees D, King L, Ifederu A, Harvey K, Hall K, Lloyd G, Morrell C, Hillier S.
    Clin Chem; 2014 Feb 05; 60(2):373-80. PubMed ID: 24158758
    [Abstract] [Full Text] [Related]

  • 19. A high-throughput newborn screening approach for SCID, SMA, and SCD combining multiplex qPCR and tandem mass spectrometry.
    Tesorero R, Janda J, Hörster F, Feyh P, Mütze U, Hauke J, Schwarz K, Kunz JB, Hoffmann GF, Okun JG.
    PLoS One; 2023 Feb 05; 18(3):e0283024. PubMed ID: 36897914
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.